Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.53 |
| ▸ | P4HA1 | P13674 | 3/20 | 0.52 |
| ▸ | P4HTM | Q9NXG6 | 2/20 | 0.52 |
| ▸ | MIF | P14174 | 1/20 | 0.50 |
| ▸ | HCAR3 | P49019 | 7/20 | 0.49 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.48 |
| ▸ | GABRP | O00591 | 1/20 | 0.48 |
| ▸ | GABRD | O14764 | 1/20 | 0.48 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.48 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.48 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.48 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.48 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.48 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.48 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.48 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.48 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.48 |
| ▸ | GABRE | P78334 | 1/20 | 0.48 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.48 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3189981 | 0.76 | TSHR (0.59) | NAPRTALDH1A1CYP2C9HPGDDAO | |
| SCHEMBL3191806 | 0.76 | TSHR (0.59) | NAPRTALDH1A1CYP2C9HPGDDAO | |
| SCHEMBL407288 | 0.75 | KMT2A (0.34) | LDHAP4HTMGABRA5MAPTLMNA | |
| Hydrochloric Acid SCHEMBL31564940 | 0.74 | TSHR (0.56) | NAPRTALDH1A1CYP2C9HPGDDAO | |
| Benzoic Acid SCHEMBL12230948 | 0.73 | TSHR (0.70) | NAPRTALDH1A1CYP2C9CYP2C19HSD17B10 | |
| SCHEMBL8521764 | 0.69 | P4HTM (0.73) | LDHAP4HA1P4HTMMIFHCAR3 | |
| SCHEMBL505455 | 0.69 | LDHA (1.00) | LDHAP4HA1P4HTMMIFHCAR3 | |
| Terephthalic Acid SCHEMBL107594 | 0.69 | CA2 (0.56) | NAPRTDAOTSHRCES2CES1 | |
| SCHEMBL68560 | 0.69 | P4HTM (1.00) | LDHAP4HA1P4HTMMIFHCAR3 | |
| SCHEMBL29683317 | 0.69 | P4HTM (1.00) | LDHAP4HA1P4HTMMIFHCAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120020881-A1 | Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2012-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120020881-A1 | Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes | KIT, STS, TST | LDHA 3696/4885P4HA1 4200/4885P4HTM 4160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.